Some of the features of BioRunUp.com include:

- Detailed Reports on Upcoming FDA and Clinical Trial Trades
- Weekly Video Watchlist

- REAL TIME Posting of Trades (Entries and Exits)
- Clinical and Regulatory Catalyst Database with over 400 events and updated daily
- Members Only Live Interactive Webinars
- Live Chat Room
- Video Lessons / Trade Reviews
- SMS Alerts of breaking biotech news
- Access to our trading accounts 
- Watch FOUR Profitable Biotech Traders in Real Time
- A More Detailed FDA Calendar
- Historical FDA Tracker
- Bio-Pharma, FDA, Clinical Trials, and Stock Market News Updates
- Direct Email Communication
- Affiliate Program

The cost for an annual subscription is $697 and includes all the above features. We also offer a monthly plan for $99.95

 - Click here to join BioRunUp -


Download our 25 page interview with the Income&Assets Letter


Sign up for our free newsletter. 
It’s the best way to stay informed about upcoming catalysts, new website content, and special announcements / offers.

 


Recent Profits of over $1,200,000


Take a look at excerpts from BioRunUp subscriber testimonials:

"My most recent and profitable trade are the EXAS Oct $5 options which I purchased at $.40 off of BioRunUp blog alert. They are currently yielding a 700% return!!!"

"Within 1 month my brand new porfolio was up over 23%!"

"In the first month I made a 13% return, doubling the return of the market as a whole - without leverage. To date, I have never failed to beat the market when applying the methods outlined in the pages of BioRunUp."

"I don’t ever take recommendations from people on the Internet, but this one looked right, felt right and sounded right. Thanks BioRunUp, you made me a fortune."


To read more testimonials, click HERE

 

 

Recent articles

 

5/28/15 Webinar Available for On-Demand Viewing

(in: Articles)
 

$XOMA Reaches Long Awaited Target Events In Phase 3 Trial

(in: Articles)
 

5/27/15 Catalyst Calendar Update

(in: Articles)
 

BioRunUp Webinar - Thursday 5/28/15 4:30pm EDT

(in: Articles)
 

$KMPH KemPharm: Abuse-Deterrent Pain Drug Developer With Recent IPO

(in: Articles)
 

$PRTK Paratek Pharma: Under The Radar Late-Stage Antibiotic Developer

(in: Articles)
 

$SYN Synthetic Biologics: Multiple Clinical Catalysts In 2015

(in: Articles)
 

This Week's Watchlist 5/26/15

(in: Articles)
 

$MEIP MEI Pharma Looks To Rebound From Phase 2 Setback

(in: Articles)
 

$IPCI Intellipharma: New Approvals Key To Future Growth Prospects

(in: Articles)
 

$COLL Collegium Pharma: Recent IPO With PDUFA Catalyst

(in: Articles)
 

This Week's Watchlist 5/18/15

(in: Articles)
 

5/14/15 Webinar Available for On-Demand Viewing

(in: Articles)
 

$TRIB Trinity Bio: Diagnostics Specialist With A Pair of 3Q15 Catalysts

(in: Articles)
 

ASCO 2015 Small-Cap Cancer Biotech Preview

(in: Articles)
 

$IMNP Immune Pharma: Multiple Catalysts Expected In 2015

(in: Articles)
 

$STEM StemCells: Turnaround Play In Regenerative Medicine Space

(in: Articles)
 

5/13/15 Catalyst Summary

(in: Articles)
 

$NEOT Neothetics: Cosmetic Medicine Specialist Targeting Spot Fat Reduction

(in: Articles)
 

BioRunUp Webinar - Thursday 5/14/15

(in: Articles)